{"analyses":[{"ciLowerLimit":"-3.37","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.81","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.5563","paramType":"Mean Difference (Net)","paramValue":"-0.78","statisticalMethod":"Mixed Models Analysis"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"-1.83","upperLimit":"2.22","value":"0.19"},{"groupId":"OG001","lowerLimit":"-0.99","upperLimit":"2.93","value":"0.97"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"66"},{"groupId":"OG001","value":"63"}],"units":"Participants"}],"description":"Change in Short Form-36 (SF-36 version 2) questionnaire Physical Component Summary \\[PCS\\] Score. PCS scores are calculated based on responses to specific Short Form-36 (version 2) questions using a weight scoring method. The lower the PCS score the more disability, the higher the score the less disability. A score of 50 is the mean in the US General Population and the standard deviation is 10. Minimum is 0 and maximum value is 100.","dispersionType":"95% Confidence Interval","groups":[{"description":"NEOD001, 24 mg/kg IV every 4 weeks for 12 months","id":"OG000","title":"NEOD001 24mg/kg"},{"description":"Placebo, 0.9% Saline IV every 4 weeks for 12 months","id":"OG001","title":"Placebo"}],"paramType":"LEAST_SQUARES_MEAN","populationDescription":"ITT population","reportingStatus":"POSTED","timeFrame":"Baseline to 12 months of treatment","title":"SF-36v2 PCS Score","type":"SECONDARY","unitOfMeasure":"score on a scale"}